Construction and validation of a model based on immunogenic cell death-associated lncRNAs to predict prognosis and direct therapy for kidney renal clear cell carcinoma

Chenxi Cai; Kexin Shu; Wanying Chen; Jiatong Ding; Zishun Guo; Yiping Wei; Wenxiong Zhang

doi:doi:10.18632/aging.204741

← Back

Research Paper

Construction and validation of a model based on immunogenic cell death-associated lncRNAs to predict prognosis and direct therapy for kidney renal clear cell carcinoma

Figure 7. Tumor mutation burden in different risk groups. Percentage bar graph showing TMB for different risk subgroups (A); High-risk group waterfall chart (B); Low-risk group waterfall chart (C).